Arbutus Biopharma Corp - Common Shares, without par value (ABUS)
CUSIP: 03879J100
Q3 2016 13F Holders as of 30 Sep 2016
- Type / Class
- Equity / Common Shares, without par value
- Shares outstanding
- 194,990,877
- Total 13F shares
- 33,443,140
- Share change
- +15,894,704
- Total reported value
- $115,042,069
- Put/Call ratio
- 355%
- Price per share
- $3.44
- Number of holders
- 46
- Value change
- +$54,657,856
- Number of buys
- 22
- Number of sells
- 18
Quarterly Holders Quick Answers
What is CUSIP 03879J100?
CUSIP 03879J100 identifies ABUS - Arbutus Biopharma Corp - Common Shares, without par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 03879J100:
Top shareholders of ABUS - Arbutus Biopharma Corp - Common Shares, without par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| PRIMECAP MANAGEMENT CO/CA/ |
13F
|
Company |
2%
|
3,850,000
|
$13,398,000 | — | 30 Jun 2016 | |
| Alpha Wave Global, LP |
13F
|
Company |
1.3%
|
2,618,000
|
$9,111,000 | — | 30 Jun 2016 | |
| HealthCor Management, L.P. |
13F
|
Company |
1.2%
|
2,258,300
|
$7,859,000 | — | 30 Jun 2016 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.89%
|
1,741,895
|
$6,062,000 | — | 30 Jun 2016 | |
| SABBY MANAGEMENT, LLC |
13F
|
Company |
0.6%
|
1,176,031
|
$4,093,000 | — | 30 Jun 2016 | |
| BANK OF MONTREAL /CAN/ |
13F
|
Company |
0.42%
|
810,785
|
$2,822,000 | — | 30 Jun 2016 | |
| AXA S.A. |
13F
|
Company |
0.41%
|
792,358
|
$2,757,000 | — | 30 Jun 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.35%
|
680,546
|
$2,368,000 | — | 30 Jun 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.3%
|
586,076
|
$2,040,000 | — | 30 Jun 2016 | |
| SUFFOLK CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.23%
|
441,915
|
$1,538,000 | — | 30 Jun 2016 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
0.21%
|
408,000
|
$1,420,000 | — | 30 Jun 2016 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
0.15%
|
300,000
|
$1,044,000 | — | 30 Jun 2016 | |
| I.G. INVESTMENT MANAGEMENT, LTD. |
13F
|
Company |
0.13%
|
250,000
|
$870,000 | — | 30 Jun 2016 | |
| BAILARD, INC. |
13F
|
Company |
0.11%
|
215,000
|
$748,000 | — | 30 Jun 2016 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.1%
|
186,993
|
$650,000 | — | 30 Jun 2016 | |
| BAKER BROS. ADVISORS LP |
13F
|
Company |
0.09%
|
180,582
|
$628,000 | — | 30 Jun 2016 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.09%
|
176,190
|
$613,000 | — | 30 Jun 2016 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
99,853
|
$347,000 | — | 30 Jun 2016 | |
| MARINER INVESTMENT GROUP LLC |
13F
|
Company |
0.05%
|
89,800
|
$313,000 | — | 30 Jun 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.04%
|
78,215
|
$272,000 | — | 30 Jun 2016 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.04%
|
75,000
|
$261,000 | — | 30 Jun 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.03%
|
66,677
|
$232,000 | — | 30 Jun 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.03%
|
66,076
|
$230,000 | — | 30 Jun 2016 | |
| K2 PRINCIPAL FUND, L.P. |
13F
|
Company |
0.03%
|
63,550
|
$221,000 | — | 30 Jun 2016 | |
| MACKENZIE FINANCIAL CORP |
13F
|
Company |
0.02%
|
39,900
|
$139,000 | — | 30 Jun 2016 | |
| CITIGROUP INC |
13F
|
Company |
0.02%
|
36,860
|
$128,000 | — | 30 Jun 2016 | |
| TFS CAPITAL LLC |
13F
|
Company |
0.02%
|
30,860
|
$107,000 | — | 30 Jun 2016 | |
| PDT Partners, LLC |
13F
|
Company |
0.02%
|
30,200
|
$105,000 | — | 30 Jun 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.01%
|
25,920
|
$90,000 | — | 30 Jun 2016 | |
| Stanley-Laman Group, Ltd. |
13F
|
Company |
0.01%
|
25,722
|
$90,000 | — | 30 Jun 2016 | |
| DIALECTIC CAPITAL MANAGEMENT, LP |
13F
|
Company |
0.01%
|
25,000
|
$87,000 | — | 30 Jun 2016 | |
| FMR LLC |
13F
|
Company |
0.01%
|
19,200
|
$67,000 | — | 30 Jun 2016 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.01%
|
13,190
|
$46,000 | — | 30 Jun 2016 | |
| STATE STREET CORP |
13F
|
Company |
0.01%
|
12,469
|
$43,000 | — | 30 Jun 2016 | |
| GROUP ONE TRADING LLC |
13F
|
Company |
0.01%
|
12,374
|
$43,000 | — | 30 Jun 2016 | |
| WEDBUSH SECURITIES INC |
13F
|
Company |
0.01%
|
12,000
|
$42,000 | — | 30 Jun 2016 | |
| Jefferies Group LLC |
13F
|
Company |
0.01%
|
11,200
|
$39,000 | — | 30 Jun 2016 | |
| Cutler Group LLC / CA |
13F
|
Company |
0.01%
|
10,780
|
$37,000 | — | 30 Jun 2016 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.01%
|
10,624
|
$37,000 | — | 30 Jun 2016 | |
| SIMPLEX TRADING, LLC |
13F
|
Company |
0%
|
7,110
|
$24,000 | — | 30 Jun 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
6,078
|
$21,000 | — | 30 Jun 2016 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0%
|
2,995
|
$10,000 | — | 30 Jun 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
2,282
|
$8,000 | — | 30 Jun 2016 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0%
|
1,850
|
$6,000 | — | 30 Jun 2016 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
1,400
|
$6,000 | — | 30 Jun 2016 | |
| Creative Planning |
13F
|
Company |
0%
|
1,000
|
$3,000 | — | 30 Jun 2016 | |
| US BANCORP \DE\ |
13F
|
Company |
0%
|
250
|
$1,000 | — | 30 Jun 2016 | |
| Sonora Investment Management, LLC |
13F
|
Company |
0%
|
20
|
$70 | — | 30 Jun 2016 |
Institutional Holders of Arbutus Biopharma Corp - Common Shares, without par value (ABUS) as of Q3 2016
As of 30 Sep 2016,
Arbutus Biopharma Corp - Common Shares, without par value (ABUS) was held by
46 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,443,140 shares.
The largest 10 holders included
QVT Financial LP, PRIMECAP MANAGEMENT CO/CA/, Falcon Edge Capital LP, HealthCor Management, L.P., D. E. Shaw & Co., Inc., ARMISTICE CAPITAL, LLC, SABBY MANAGEMENT, LLC, BANK OF MONTREAL /CAN/, AXA, and GOLDMAN SACHS GROUP INC.
This page lists
46
institutional shareholders reporting positions in this security
for the Q3 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2016 vs Q2 2016 Across Filers
Q2 2016 holders
47
Q3 2016 holders
46
Holder diff
-1
| Investor | Q2 2016 Shares | Q3 2016 Shares | Share Diff | Share Chg % | Q2 2016 Value $ | Q3 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.